home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Novozymes launches updated strategy - The strategy will enable more growth and value from the core business and make it possible to invest in new longer-term opportunities


Denmark
June 16, 2019



 

Today, Novozymes announced the path to drive stronger growth over the three-year period 2020-2022. The updated strategy and consequent adjustments focus on better utilization of Novozymes’ core capabilities, making it possible to better prioritize high-impact pipeline projects, invest in new longer-term strategic opportunity areas and drive stronger commercial execution.

In the three-year period 2020-2022, Novozymes targets 5+% annual organic sales growth with 2020 likely negatively impacted by portfolio changes. By 2022, the company expects the EBIT margin to be at 28% or above and ROIC incl. goodwill at 23% or above.

“We will free up DKK 200-300 million from our existing portfolios, as well as from simplification and efficiency improvements. We will reinvest a significant part of that in new strategic opportunities, high-growth projects and commercial activities that generate improved performance over the coming years and create significant options and results for Novozymes and its stakeholders," says CEO Peder Holk Nielsen.

Setting the future direction

During the past years, Novozymes has developed a strong market position and today supplies biological solutions to more than 30 different industries. Its enzymatic and microbial solutions help bring biological answers to many of the global challenges we face today. 

Overall, the financial performance is strong across key financials, but Novozymes has not delivered its full growth potential. External factors have had a negative impact on the business, and the company has not performed as expected.

“The updated corporate strategy, Better business with biology, sets the direction for Novozymes and will ensure that we will create more impact for our customers, for our business and for the world than we do today,” says CEO Peder Holk Nielsen.

Read more in the company’s official stock exchange announcement here 

Non-financial targets by 2022

Novozymes has defined commitments for 2030 and targets for 2020-22 for three global challenges:

  • Climate - Save 60 million tons of CO2 in the transport sector
  • Water - Reach more than 4 billion people with laundry solutions
  • Production & Consumption: Gain 500,000 tons of food by improving farm-to-table efficiency


More news from: Novonesis


Website: https://www.novonesis.com/en

Published: June 17, 2019

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section

 


Copyright @ 1992-2025 SeedQuest - All rights reserved